Internal Medicine Alert – December 15, 2020
December 15, 2020
View Issues
-
Treating Hypertension Without Drugs
High flavanol intake was associated with lower blood pressure in men and women comparable to what is seen with a Mediterranean diet or moderate salt restriction.
-
Rhythm vs. Rate Control for Atrial Fibrillation Patients: The Controversy Continues
Early use of rhythm control in patients with atrial fibrillation and high cardiovascular risk appears to improve cardiovascular outcomes compared to usual care.
-
Rifampin vs. Isoniazid for Latent Tuberculosis
A health system cost comparison showed that four months of rifampin was safer and less expensive than nine months of isoniazid in high-income countries, medium-income countries, and African countries.
-
When Aortic Stenosis Is Almost Severe: What Happens Next?
A study of patients with normal flow, low gradients, normal left ventricular systolic function but with calculated aortic valve areas <1.0 cm2 showed that about half of them progressed to severe aortic stenosis during the 25-month median follow-up period.
-
Bamlanivimab Injection
Bamlanivimab is a neutralizing recombinant IgG1 monoclonal antibody that connects to the receptor-binding domain of the spike protein of SARS-CoV-2. The drug blocks attachment and entry of the virus into human cells.
-
Is There Bundle Branch Block?
Try to interpret the ECG in the figure without the benefit of any clinical information. What do you see?